Bluebird Bio reports positive early safety data from Ph I CAR-T trial
Bluebird Bio has reported encouraging efficacy and safety data from a Phase I trial of its CAR-T multiple myeloma therapy, bb2121.
Archives for December 2, 2016
Valitacell moves into NIBRT lab space to further develop cell lines
Valitacell has moved into the National Institute for Bioprocessing Research and Training (NIBRT) as it works to further develop its cell performance technologies.
Arrowhead fires CSO & Co-inventor of delivery tech responsible for clinical trial abandonment
Arrowhead Pharmaceuticals Inc. has also laid off its Chief scientific officer David Lewis - as part of the 34 staff cull - after several trials using delivery vehicle Ex1 were stopped by the firm.